Trial · NCT02806791
Efficacy of Biosimilar Filgrastim on the Mobilization of Hematopoietic Stem Cell CD34+ (Cluster of Differentiation 34) and on the Kinetic Engraftment
NCT02806791, Unknown, Azienda Ospedaliera San Giovanni Battista
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Efficacy of Biosimilar Filgrastim on the Mobilization of Hematopoietic Stem Cell CD34+ (Cluster of Differentiation 34) and on the Kinetic Engraftment. Trials, record NCT02806791. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02806791
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Efficacy of Biosimilar Filgrastim on the Mobilization of Hematopoietic Stem Cell CD34+ (Cluster of Differentiation 34) and on the Kinetic Engraftment
- NCT number
- NCT02806791
- Status
- Unknown
- Enrollment
- 300 participants, actual
- Lead sponsor
- Azienda Ospedaliera San Giovanni Battista
- Conditions
- Blood Diseases
- Interventions
- FILGRASTIM
- First posted
- 2016-06-21
- Last updated
- 2016-06-21
Source ClinicalTrials.gov
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Collection of autologous stem cells (time the median of achieving> 20 CD34 + / ul circulating) | until reaching 20,000 platelets (2006-2015) | |
| Primary | Trend in blood counts after discharge values | Until day +75 post autologous transplantation (2006-2015) | |
| Primary | Collection of autologous stem cells (total hematopoietic stem cells CD34 + * 10 ^ 6 / kg collected) | at the moment of the collection of autologous stem cells (2006-2015) | |
| Primary | Collection of autologous stem cells (the median time from the first day of chemotherapy mobilizing) | from the first day of chemotherapy mobilizing (2006-2015) | the median time (in days) from the first day of chemotherapy mobilizing the effective collection of stem cells |
| Primary | Collection of autologous stem cells (the median number of leukapheresis performed) | at the moment of the collection of autologous stem cells (2006-2015) | |
| Primary | Collection of autologous stem cells (median number of white blood cells) | at the moment of the collection of autologous stem cells | the median number of white blood cells in the process of mobilization |
| Primary | Collection of autologous stem cells ( with the aid of Plerixafor) | at the moment of the collection of autologous stem cells (2006-2015) | the proportion of patients who have the mobilized peripheral blood stem cells with the aid of Plerixafor |
| Primary | Engraftment after autologous transplantation (granulocyte and platelet engraftment) | from transplant to engraftment (2006-2015) | cumulative incidence of granulocyte and platelet engraftment |
| Primary | Engraftment after autologous transplantation ( median time to achieve neutrophils> 500) | from transplant to platelets engraftment (2006-2015) | the median time to achieve neutrophils\> 500 / ul for 3 consecutive days / platelets\> 20,000 / ul for 7 consecutive days |
| Primary | Engraftment after autologous transplantation (the median number of days of G-CSF administration) | from transplant to engraftment (2006-2015) |
1 to 10 of 15Source ClinicalTrials.gov
See all 15 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02806791
GET https://conductscience.org/api/trials/v1/NCT02806791/registered